LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.84 | 84.90 | 4109 | 4003 | 1.0264 | 1.0094 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.55 | 84.90 | 115 | 4287 | 0.0268 | 0.0551 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.55 | 84.90 | 3623 | 4287 | 0.8449 | 0.9413 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.55 | 84.90 | 4361 | 4287 | 1.0170 | 1.0060 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.55 | 84.90 | 4400 | 4287 | 1.0261 | 1.0091 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.25 | 84.90 | 140 | 4539 | 0.0308 | 0.0910 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.25 | 84.90 | 3977 | 4539 | 0.8760 | 0.9544 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.25 | 84.90 | 4702 | 4539 | 1.0357 | 1.0123 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.25 | 84.90 | 4737 | 4539 | 1.0434 | 1.0149 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 46.95 | 84.90 | 144 | 4952 | 0.0291 | 0.0943 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 46.95 | 84.90 | 4232 | 4952 | 0.8545 | 0.9471 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 46.95 | 84.90 | 4953 | 4952 | 1.0001 | 1.0000 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 46.95 | 84.90 | 4996 | 4952 | 1.0088 | 1.0030 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 48.65 | 84.90 | 103 | 5328 | 0.0193 | 0.0329 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 48.65 | 84.90 | 4547 | 5328 | 0.8533 | 0.9476 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 48.65 | 84.90 | 5234 | 5328 | 0.9822 | 0.9940 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 48.65 | 84.90 | 5266 | 5328 | 0.9882 | 0.9960 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 50.36 | 84.90 | 212 | 5651 | 0.0375 | 0.1631 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 50.36 | 84.90 | 4802 | 5651 | 0.8498 | 0.9470 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 50.36 | 84.90 | 5574 | 5651 | 0.9864 | 0.9955 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 50.36 | 84.90 | 5634 | 5651 | 0.9970 | 0.9990 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 52.06 | 84.90 | 211 | 5990 | 0.0352 | 0.1598 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 52.06 | 84.90 | 4960 | 5990 | 0.8279 | 0.9394 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 52.06 | 84.90 | 5956 | 5990 | 0.9942 | 0.9981 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 52.06 | 84.90 | 6039 | 5990 | 1.0080 | 1.0026 | MN20160318_Q02 | I04 |